Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Net Equity Issued and Repurchased (2010 - 2021)

Geron (GERN) posted Net Equity Issued and Repurchased of $4.2 million for Q4 2021, down 74.43% sequentially from $16.2 million in Q1 2021.

Geron (GERN) Net Equity Issued and Repurchased (2010 - 2021) Analysis & Trends

Geron has reported Net Equity Issued and Repurchased for 12 years, with the latest figure at $4.2 million in Q4 2021.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $20.4 million (up 400.25% YoY) and the FY2021 annual result came in at $20.4 million, up 400.25% from the prior year.
  • Net Equity Issued and Repurchased declined to $4.2 million in Q4 2021 per GERN's latest filing, from $16.2 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $82.3 million in Q2 2018 and troughed at -$6.9 million in Q4 2018.
  • A 5-year average of $11.9 million and a median of $4.2 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2017 and 2018: Net Equity Issued and Repurchased jumped 8425.0% in 2017, then plunged 778.69% in 2018.
  • Over 5 years, Net Equity Issued and Repurchased stood at $1.0 million in 2017, then slumped by 778.69% to -$6.9 million in 2018, then soared by 247.41% to $10.2 million in 2019, then plunged by 66.89% to $3.4 million in 2020, then climbed by 22.48% to $4.2 million in 2021.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $4.2 million, $16.2 million, and $3.4 million for Q4 2021, Q1 2021, and Q2 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Geron 1.02 Mn -299.83 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 4.15 Mn
Dec 31, 2021 4.15 Mn
Mar 31, 2021 16.23 Mn
Mar 31, 2021 16.23 Mn
Jun 30, 2020 3.39 Mn
Jun 30, 2020 3.39 Mn
Mar 31, 2020 686,000.00
Mar 31, 2020 686,000.00
Dec 31, 2019 10.24 Mn
Dec 31, 2019 10.24 Mn
Sep 30, 2019 8.82 Mn
Sep 30, 2019 8.82 Mn
Dec 31, 2018 -6.94 Mn
Dec 31, 2018 -6.94 Mn
Sep 30, 2018 9.09 Mn
Sep 30, 2018 9.09 Mn
Jun 30, 2018 82.32 Mn
Jun 30, 2018 82.32 Mn
Mar 31, 2018 1.55 Mn
Mar 31, 2018 1.55 Mn